MAKE APPOINTMENT

AbbVie’s Experimental Cancer Drug Temab-A Earns Two FDA Breakthrough Designations for Advanced Colorectal and Lung Cancers

by | Oct 10, 2026 | Uncategorized | 0 comments

FDA gave AbbVie’s Temab-A two breakthrough designations for advanced colorectal and lung cancers. What the status means and what patients should know.

Submit a Comment

Your email address will not be published. Required fields are marked *